Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

43.03
Delayed Data
As of Sep 22
 +1.01 / +2.40%
Today’s Change
32.76
Today|||52-Week Range
43.77
+7.04%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close42.02
Today’s open42.04
Day’s range41.91 - 43.06
Volume240,207
Average volume (3 months)295,553
Market cap$2.2B
Dividend yield--
Data as of 4:02pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+53.21%
Earnings growth (this year)+6.13%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-2.68%
P/E ratio614.7
Price/Sales2.36
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.28+0.61%
MMSIMerit Medical System...+0.20+0.49%
INGNInogen Inc-1.12-1.09%
NXTMNxStage Medical Inc+0.02+0.07%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)$0.41
Annual revenue (last year)$886.1M
Annual profit (last year)-$26.3M
Net profit margin-2.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts